Sylvie Dusilová-Sulková

Sylvie Dusilová-Sulková

Auto-generated profile, based on publicly available information

Sylvie Dusilová-Sulková

University Hospital Hradec Kralové, Hemodialysis Centre, Hradec Králové, Czech Republic

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2005 in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Verified
Journal Article
Closed access
MKMarta Kalousova
Marta Kalousova
TZTomáš Zima
Tomáš Zima
VTVladimír Tesař
Vladimír Tesař
SDSylvie Dusilová-Sulková
Sylvie Dusilová-Sulková
JŠJan Škrha
Jan Škrha

1 August 2002 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
PDF file
QMQuirino Maggiore
Quirino Maggiore
FPFrancesco Pizzarelli
Francesco Pizzarelli
ASAntonio Santoro
Antonio Santoro
GPGiovanni Panzetta
Giovanni Panzetta
GBGiuseppe Bonforte
Giuseppe Bonforte
JKJonathan T.C. Kwan
Jonathan T.C. Kwan

1 March 2006 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
MKMarta Kalousova
Marta Kalousova
MHMagdaléna Hodková
Magdaléna Hodková
MKMarkéta Kazderová
Markéta Kazderová
JFJana Fialová
Jana Fialová
VTVladimír Tesař
Vladimír Tesař
TZTomáš Zima
Tomáš Zima

1 October 2009 in Clinical Immunology
Verified
Journal Article
Closed access
KSKlára Sochorová
Klára Sochorová
VBVít Budinský
Vít Budinský
DRDaniela Rožková
Daniela Rožková
ZTZuzana Tobiasová
Zuzana Tobiasová
SDSylvie Dusilová-Sulková
Sylvie Dusilová-Sulková
JBJiřina Bartůňková
Jiřina Bartůňková

1 August 2002 in The International Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
FLFrantišek Lopot
František Lopot
BNB. Nejedlý
B. Nejedlý
HNH. Novotná
H. Novotná
MMM. Macková
M. Macková
SSS. Sulková
S. Sulková
The article suggests a novel method for quantitative determination of optimal dry weight in dialysis patient based on their extracellular volume (ECV) to total body water (TBW) ratio and its relation to age. Values of ECV and TBW are evaluated by means of whole body multifrequency bioimpedometry. In an effort to find a suitable marker of hydration status in an individual from bioimpedance data, significant correlation has been found between ECV/TBW ratio and age in health. Assuming that all excess fluid in dialysis patients is stored exclusively in ECV and that distribution of their TBW at the state of optimal dry weight corresponds to that of a healthy person of the same age, the pre-dialysis ECV/TBW could be used for quantitative determination of optimal dry weight and/or of the ultrafiltration to reach this weight. Practical bioimpedance measurement of ECV/TBW in a group of dialysis patients both pre- and post-dialysis confirmed both above assumptions, i.e. nearly exclusively extracellular origin of ultrafiltration as well as normalisation of the ECV/TBW ratio towards the end of dialysis. Supporting evidence of increasing ECV/TBW value with age was also found in literature. Although the suggested method needs detailed analysis of possible disturbing factors (ethnic “specificity” of the reference ECV/TBW vs. age characteristics in health, possible difference in “biological” and “physical” age of dialysis patient and others), the article is published at this early stage to enable wider testing of the proposed novel method by different investigators.

2 February 2004 in Kidney and Blood Pressure Research
Verified
Journal Article
Closed access
MKMarta Kalousova
Marta Kalousova
TZT. Zima
T. Zima
VTV. Tesař
V. Tesař
SŠS. Štípek
S. Štípek
SSS. Sulková
S. Sulková
As a result of oxidative and carbonyl stress, advanced glycation end products (AGEs) are involved in the pathogenesis of severe and frequent diseases and their fatal vascular/cardiovascular complications, i.e. diabetes mellitus and its complications (nephropathy, angiopathy, neuropathy and retinopathy, renal failure and uremic and dialysis-associated complications), atherosclerosis and dialysis-related amyloidosis, neurodegenerative diseases, and rheumatoid arthritis. They are formed via non-enzymatic glycation which is specifically enhanced through the presence of oxidative and carbonyl stress, and their ability to form glycoxidation products in peptide and protein structures finally modulating or inducing biological reactivity. Food can be another source of AGEs; however, high serum AGEs in hemodialysis patients might reflect nutritional status better. Several methods of renal replacement therapy have been studied in connection with the AGE removal, but unfortunately the possibilities are still unsatisfactory even if high flux dialysis, hemofiltration, or hemodiafiltration give better results than conventional low flux dialysis. AGEs are currently being studied in the patients on peritoneal dialysis as their precursors can be formed in the dialysis fluid. AGEs can cause damage to the peritoneum and so a loss of ultrafiltration capacity. Many compounds give promising results in AGE inhibition (inhibition of formation of AGEs, inhibition of their action or degradation of AGEs), are tested for these properties, and eventually undergo clinical studies (e.g. aminoguanidine, OPB-9195, pyridoxamine, antioxidants, N-phenacylthiazolium bromide, antihypertensive drugs, angiotensin-converting enzyme inhibitors and angiotensin II receptor-1 antagonists).